Clinical Trial Update: A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Celecoxib to Diclofenac in adults with ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Celecoxib (Celecoxib)
• Diclofenac (diclofenac)

Snippet

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED